Business Wire

CGTN: China Eyes Good Start to 14th Five-Year Plan Period Ahead of Spring Festival

Share

A New Year is a new beginning. With this year's Spring Festival, or the Chinese Lunar New Year, just around the corner, China is also well prepared for the beginning of the 14th Five-Year Plan (FYP) period (2021-2025) and the centenary of the Communist Party of China (CPC).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210210005816/en/

Ahead of the Spring Festival, Chinese President Xi Jinping extended Spring Festival greetings to all Chinese Wednesday at a reception in Beijing and called for a good start in boosting the country's development during the 14th FYP period so as to celebrate the Party's centenary with outstanding achievements.

Ready for a new journey in the 14th FYP period

Facts have once again proven that the system of socialism with Chinese characteristics has incomparable vitality and creativity, Xi said.

As long as the entire Party and the Chinese people of all ethnic groups rally closely around the CPC Central Committee, there is no difficulty that cannot be overcome, he said.

The year 2021 is crucial to China as the nation is set to achieve its first centenary goal within the set time frame – to complete the building of a moderately prosperous society in all respects – and begin the work towards the second goal, to fully build a modern socialist country.

Stressing the goal of promoting high-quality development, President Xi highlighted the importance of the country's new stage of development, the implementation of this new vision of development, and the construction of a new pattern of development in 2021.

To meet the people's ever-growing needs for a better life, efforts are needed in deepening supply-side structural reform while taking reform and innovation as the fundamental driving force, the Chinese president said.

Consolidating and expanding achievements in epidemic containment and economic and social development are necessary, he added.

Great achievements in 2020 as solid foundation

President Xi also looked back on the past year which he described as "extraordinary" in his New Year speech.

Xi hailed what has achieved in COVID-19 prevention, poverty alleviation, flood prevention, rescue and relief work, and reform and opening-up, and highlighted the country's progress in technology, economy and the Belt and Road construction.

China is one of the most resilient economies amid the ravaging pandemic and global economic slump. The country was among the first to have put the virus under control, to have resumed work and production and to have realized economic stability and recovery, which not only made it the first major economy in the world to register positive growth in 2020 but also brought confidence and hope to others in the world.

On November 23, as southwest China's Guizhou Province cleared all the names on its poverty list, China announced the eradication of absolute poverty and regional poverty.

At a symposium on securing a decisive victory in poverty alleviation in March, President Xi said lifting all rural residents living below the poverty line out of poverty by 2020 is a solemn promise made by the CPC Central Committee and it must be fulfilled on time.

Original article: here.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Jiang Simin
jiang.simin@cgtn.com
+86 18826553286

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release

Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i

Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct

Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release

Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we

Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release

AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by

illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release

illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye